Marco Mirani

1.7k total citations
28 papers, 821 citations indexed

About

Marco Mirani is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Marco Mirani has authored 28 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 5 papers in Infectious Diseases. Recurrent topics in Marco Mirani's work include Diabetes Treatment and Management (10 papers), Diabetes Management and Research (9 papers) and Metabolism, Diabetes, and Cancer (7 papers). Marco Mirani is often cited by papers focused on Diabetes Treatment and Management (10 papers), Diabetes Management and Research (9 papers) and Metabolism, Diabetes, and Cancer (7 papers). Marco Mirani collaborates with scholars based in Italy, United States and Hungary. Marco Mirani's co-authors include Andrea Lania, Gherardo Mazziotti, Tomoshige Kino, Elisabetta Lavezzi, Maria Teresa Sandri, George P. Chrousos, Miriam Cellini, Massimo U. De Martino, Evangelia Charmandari and Giuseppe Favacchio and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Diabetes.

In The Last Decade

Marco Mirani

25 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Mirani Italy 14 419 249 129 119 87 28 821
Xie Wu United States 11 310 0.7× 126 0.5× 124 1.0× 86 0.7× 63 0.7× 18 849
Konstantinos Michalakis Greece 14 219 0.5× 119 0.5× 106 0.8× 49 0.4× 92 1.1× 24 884
Linda Hilsted Denmark 19 391 0.9× 117 0.5× 191 1.5× 60 0.5× 229 2.6× 54 1.0k
Lluís Masmiquel Spain 17 167 0.4× 118 0.5× 159 1.2× 28 0.2× 130 1.5× 68 806
Laura A. Bienvenu Australia 10 234 0.6× 119 0.5× 122 0.9× 33 0.3× 156 1.8× 14 587
Edison Jahaj Greece 17 103 0.2× 338 1.4× 130 1.0× 31 0.3× 43 0.5× 73 735
Rossella Tozzi Italy 12 229 0.5× 212 0.9× 95 0.7× 68 0.6× 75 0.9× 23 793
H.P. Sauerwein Netherlands 16 145 0.3× 97 0.4× 127 1.0× 77 0.6× 90 1.0× 41 953
Ayşegül Atmaca Türkiye 14 201 0.5× 74 0.3× 68 0.5× 66 0.6× 104 1.2× 45 512
Giuseppina Rosaria Umano Italy 21 408 1.0× 33 0.1× 181 1.4× 104 0.9× 179 2.1× 79 1.2k

Countries citing papers authored by Marco Mirani

Since Specialization
Citations

This map shows the geographic impact of Marco Mirani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Mirani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Mirani more than expected).

Fields of papers citing papers by Marco Mirani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Mirani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Mirani. The network helps show where Marco Mirani may publish in the future.

Co-authorship network of co-authors of Marco Mirani

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Mirani. A scholar is included among the top collaborators of Marco Mirani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Mirani. Marco Mirani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mirani, Marco, et al.. (2025). GLP-1R Agonists Improve Ocular Surface Parameters in Type 2 Diabetes Mellitus. Clinical ophthalmology. Volume 19. 3829–3836.
2.
Grancini, Valeria, et al.. (2025). Role of Medical Nutrition Therapy as Treatment of Sarcopenia in Older People with Type 2 Diabetes. Nutrients. 17(1). 172–172. 2 indexed citations
3.
Vena, Walter, Marco Mirani, Vincenzo Altieri, et al.. (2025). Diabetic Ketoacidosis: Considerations and Residual Controversies in Management After the 2024 ADA, EASD, JBDS, AACE, and DST Joint Consensus. Endocrine Metabolic & Immune Disorders - Drug Targets. 25.
4.
Vena, Walter, et al.. (2024). COVID-19 vaccines and blood glucose control: Friend or foe?. Human Vaccines & Immunotherapeutics. 20(1). 2363068–2363068. 1 indexed citations
5.
Favacchio, Giuseppe, et al.. (2024). Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists. Diabetes Research and Clinical Practice. 212. 111689–111689. 8 indexed citations
6.
Berra, Cesare, Roberto Manfrini, Marco Mirani, et al.. (2023). AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus. Acta Diabetologica. 60(9). 1257–1266. 6 indexed citations
7.
Favacchio, Giuseppe, Cristina Panico, Emanuela Morenghi, et al.. (2023). Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study. Cardiovascular Diabetology. 22(1). 69–69. 35 indexed citations
8.
Berra, Cesare, Maria Chiara Rossi, Marco Mirani, et al.. (2023). Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01). Frontiers in Endocrinology. 13. 1099451–1099451. 18 indexed citations
9.
Milani, Davide, et al.. (2021). Update on vertebral fractures in pituitary diseases: from research to clinical practice. HORMONES. 20(3). 423–437. 9 indexed citations
10.
Mazziotti, Gherardo, Elisabetta Lavezzi, Alessandro Brunetti, et al.. (2021). Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19. Journal of Endocrinological Investigation. 44(10). 2285–2293. 21 indexed citations
11.
Biamonte, Emilia, Francesco Pegoraro, Giuseppe Favacchio, et al.. (2021). Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect. Endocrine. 72(3). 604–610. 55 indexed citations
12.
Berra, Cesare, Veronica Resi, Marco Mirani, et al.. (2020). Clinical efficacy and predictors of response to dulaglutide in type-2 diabetes. Pharmacological Research. 159. 104996–104996. 19 indexed citations
13.
Berra, Cesare, Elena Azzolini, Marco Mirani, et al.. (2019). Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population. Acta Diabetologica. 56(8). 931–938. 28 indexed citations
14.
Mirani, Marco, et al.. (2018). Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohort. Pharmacological Research. 137. 270–279. 16 indexed citations
15.
Mirani, Marco, Cesare Berra, Silvia Finazzi, et al.. (2010). Inter-Day Glycemic Variability Assessed by Continuous Glucose Monitoring in Insulin-Treated Type 2 Diabetes Patients on Hemodialysis. Diabetes Technology & Therapeutics. 12(10). 749–753. 46 indexed citations
16.
Agha-Alinejad, Hamid, et al.. (2010). The effects of active recovery on serum IL-6, IL-8, IL-10 and CK concentrations after eccentric strenuous exercise in active female.. Majallah-i ghudad-i darūn/rīz va mitābulīsm-i Īrān./Majallah-i ghudad-i darūn/rīz va mitābulīsm-i Īrān.. 11(5). 553–560. 3 indexed citations
17.
Ferrari, E, Marco Mirani, S. B. Solerte, et al.. (2004). COGNITIVE AND AFFECTIVE DISORDERS IN THE ELDERLY: A NEUROENDOCRINE STUDY. Archives of Gerontology and Geriatrics. 38(9). 171–182. 23 indexed citations
18.
Pantaleo, Maria A., Giovanni Brandi, Enrico Derenzini, et al.. (2004). Is adjuvant systemic chemotherapy after resection of metastases from colorectal cancer suitable?. Journal of Clinical Oncology. 22(14_suppl). 3654–3654. 1 indexed citations
19.
Kino, Tomoshige, Massimo U. De Martino, Evangelia Charmandari, Marco Mirani, & George P. Chrousos. (2003). Tissue glucocorticoid resistance/hypersensitivity syndromes. The Journal of Steroid Biochemistry and Molecular Biology. 85(2-5). 457–467. 127 indexed citations
20.
Kino, Tomoshige, et al.. (2003). AIDS-Related Lipodystrophy/Insulin Resistance Syndrome. Hormone and Metabolic Research. 35(3). 129–136. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xie Wu Breakdown of academic impact, for papers by Konstantinos Michalakis Breakdown of academic impact, for papers by Linda Hilsted Breakdown of academic impact, for papers by Lluís Masmiquel Breakdown of academic impact, for papers by Laura A. Bienvenu Breakdown of academic impact, for papers by Edison Jahaj Breakdown of academic impact, for papers by Rossella Tozzi Breakdown of academic impact, for papers by H.P. Sauerwein Breakdown of academic impact, for papers by Ayşegül Atmaca Breakdown of academic impact, for papers by Giuseppina Rosaria Umano
Rankless by CCL
2026